Magnesium Sulfate Improves Some Risk Factors for Atherosclerosis in Patients Suffering from One or Two Coronary Artery Diseases: A Double-blind Clinical Trial Study

References

• Torres N, Guevara-Cruz M, Velazquez-Villegas LA, Tovar AR. Nutrition and atherosclerosis. Arch Med Res. 2015;46(5):408–426. doi:10.1016/j.arcmed.2015.05.01026031780
   PubMed Web of Science ®Google Scholar
• Lim DH, Lee Y, Park GM, et al. Serum uric acid level and subclinical coronary atherosclerosis in asymptomatic individuals: an observational cohort study. Atherosclerosis. 2019;288:112–117. doi:10.1016/j.atherosclerosis.2019.07.01731352272
   PubMed Web of Science ®Google Scholar
• Orimo H, Ouchi Y. The role of calcium and magnesium in the development of atherosclerosis. Experimental and clinical evidence. Ann N Y Acad Sci. 1990;598:444–457. doi:10.1111/j.1749-6632.1990.tb42315.x2248457
   PubMed Web of Science ®Google Scholar
• Brinkley TE, Kume N, Mitsuoka H, et al. Variation in the human lectin‐like oxidized low‐density lipoprotein receptor 1 (LOX‐1) gene is associated with plasma soluble LOX‐1 levels. Exp Physiol. 2008;93(9):1085–1090. doi:10.1113/expphysiol.2008.04226718469066
   PubMed Web of Science ®Google Scholar
• Blum JW, Froehli D, Kunz P. Effects of catecholamines on plasma free fatty acids in fed and fasted cattle. Endocrinology. 1982;110(2):452–456. doi:10.1210/endo-110-2-4527056209
   PubMed Web of Science ®Google Scholar
• Kvetnansky R, Lu X, Ziegler MG. Stress-triggered changes in peripheral catecholaminergic systems. Adv Pharmacol. 2013;68:359–397. doi:10.1016/B978-0-12-411512-5.00017-824054153
   PubMedGoogle Scholar
• Burn J, Gibbons W. The part played by calcium in determining the response to stimulation of sympathetic postganglionic fibres. Br J Pharmacol Chemother. 1964;22(3):540–548. doi:10.1111/j.1476-5381.1964.tb01708.x14211684
   PubMed Web of Science ®Google Scholar
• Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015;14(1):6. doi:10.1186/1475-2891-14-625577237
   PubMed Web of Science ®Google Scholar
• Fang P, Zhang D, Cheng Z, et al. Hyperhomocysteinemia potentiates hyperglycemia-induced inflammatory monocyte differentiation and atherosclerosis. Diabetes. 2014;63(12):4275–4290. doi:10.2337/db14-080925008174
   PubMed Web of Science ®Google Scholar
• Ernst E. The role of fibrinogen as a cardiovascular risk factor. Atherosclerosis. 1993;100(1):1–12. doi:10.1016/0021-9150(93)90062-y8318054
   PubMed Web of Science ®Google Scholar
• Ernst E. Fibrinogen as a cardiovascular risk factor–interrelationship with infections and inflammation. Eur Heart J. 1993;14:82–87.
   Web of Science ®Google Scholar
• Zhang Y, Zhu C-G, Guo Y-L, et al. Higher fibrinogen level is independently linked with the presence and severity of new-onset coronary atherosclerosis among Han Chinese population. PLoS One. 2014;9(11):e113460. doi:10.1371/journal.pone.011346025426943
   PubMed Web of Science ®Google Scholar
• Reffelmann T, Ittermann T, Dörr M, et al. Low serum magnesium concentrations predict cardiovascular and all-cause mortality. Atherosclerosis. 2011;219(1):280–284. doi:10.1016/j.atherosclerosis.2011.05.03821703623
   PubMed Web of Science ®Google Scholar
• Maier JA. Low magnesium and atherosclerosis: an evidence-based link. Mol Aspects Med. 2003;24(3–1):137–146. doi:10.1016/s0098-2997(02)00095-x12537993
   PubMedGoogle Scholar
• Kupetsky-Rincon EA, Uitto J. Magnesium: novel applications in cardiovascular disease–a review of the literature. Ann Nutr Metab. 2012;61(2):102–110. doi:10.1159/00033938022907037
   PubMed Web of Science ®Google Scholar
• Kieboom BC, Niemeijer MN, Leening MJ, et al. Serum magnesium and the risk of death from coronary heart disease and sudden cardiac death. J Am Heart Assoc. 2016;5(1):e002707. doi:10.1161/JAHA.115.00270726802105
   PubMed Web of Science ®Google Scholar
• Cunha AR, D’El-Rei J, Medeiros F, et al. Oral magnesium supplementation improves endothelial function and attenuates subclinical atherosclerosis in thiazide-treated hypertensive women. J Hypertens. 2017;35(1):89–97. doi:10.1097/HJH.000000000000112927759579
   PubMed Web of Science ®Google Scholar
• Guo H, Lee J-D, Uzui H, et al. Effects of folic acid and magnesium on the production of homocysteine-induced extracellular matrix metalloproteinase-2 in cultured rat vascular smooth muscle cells. Circ J. 2006;70(1):141–146. doi:10.1253/circj.70.14116377938
   PubMed Web of Science ®Google Scholar
• Fazlali M, Kharazmi F, Kamran M, et al. Effect of oral magnesium sulfate administration on lectin-like oxidized low-density lipoprotein receptor-1 gene expression to prevent atherosclerosis in diabetic rat vessels. J Diabetes Investig. 2019;10(3):650–658. doi:10.1111/jdi.12961
   Web of Science ®Google Scholar
• Soltani N, Keshavarz M, Dehpour AR. Effect of oral magnesium sulfate administration on blood pressure and lipid profile in streptozocin diabetic rat. Eur J Pharmacol. 2007;560(2–3):201–205. doi:10.1016/j.ejphar.2006.12.02017292879
   PubMed Web of Science ®Google Scholar
• Soltani N, Keshavarz M, Minaii B, Mirershadi F, Zahedi Asl S, Dehpour AR. Effects of administration of oral magnesium on plasma glucose and pathological changes in the aorta and pancreas of diabetic rats. Clin Exp Pharmacol Physiol. 2005;32(8):604–610. doi:10.1111/j.0305-1870.2005.04238.x16120185
   PubMed Web of Science ®Google Scholar
• Soltani N, Keshavarz M, Sohanaki H, Zahedi Asl S, Dehpour AR. Relaxatory effect of magnesium on mesenteric vascular beds differs from normal and streptozotocin induced diabetic rats. Eur J Pharmacol. 2005;508(1–3):177–181. doi:10.1016/j.ejphar.2004.12.00315680269
   PubMed Web of Science ®Google Scholar
• Shahbah D, Hassan T, Morsy S, et al. Oral magnesium supplementation improves glycemic control and lipid profile in children with type 1 diabetes and hypomagnesaemia. Medicine. 2017;96(11):11. doi:10.1097/MD.0000000000006352
   Web of Science ®Google Scholar
• Shahi A, Aslani S, Ataollahi M, Mahmoudi M. The role of magnesium in different inflammatory diseases. Inflammopharmacology. 2019;27(4):649–661. doi:10.1007/s10787-019-00603-731172335
   PubMed Web of Science ®Google Scholar
• Cao Y, Wang C, Guan K, Xu Y, Su Y-X, Chen Y-M. Association of magnesium in serum and urine with carotid intima-media thickness and serum lipids in middle-aged and elderly Chinese: a community-based cross-sectional study. Eur J Nutr. 2016;55(1):219–226. doi:10.1007/s00394-015-0839-825750058
   PubMed Web of Science ®Google Scholar
• Severino P, Netti L, Mariani MV, et al. Prevention of cardiovascular disease: screening for magnesium deficiency. Cardiol Res Pract. 2019;2019:1–10. doi:10.1155/2019/4874921
   Web of Science ®Google Scholar
• Dong J-Y, Xun P, He K, Qin L-Q. Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care. 2011;34(9):2116–2122. doi:10.2337/dc11-051821868780
   PubMed Web of Science ®Google Scholar
• Guerrero‐Romero F, Rodríguez‐Morán M. Magnesium improves the beta‐cell function to compensate variation of insulin sensitivity: double‐blind, randomized clinical trial. Eur J Clin Invest. 2011;41(4):405–410. doi:10.1111/j.1365-2362.2010.02422.x21241290
   PubMed Web of Science ®Google Scholar
• Fang X, Wang K, Han D, et al. Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose–response meta-analysis of prospective cohort studies. BMC Med. 2016;14(1):210. doi:10.1186/s12916-016-0742-z27927203
   PubMed Web of Science ®Google Scholar
• Fang X, Han H, Li M, et al. Dose-response relationship between dietary magnesium intake and risk of type 2 diabetes mellitus: a systematic review and meta-regression analysis of prospective cohort studies. Nutrients. 2016;8(11):739. doi:10.3390/nu8110739
   Web of Science ®Google Scholar
• Rosique-Esteban N, Guasch-Ferré M, Hernández-Alonso P, Salas-Salvadó J. Dietary magnesium and cardiovascular disease: a review with emphasis in epidemiological studies. Nutrients. 2018;10(2):168. doi:10.3390/nu10020168
   PubMed Web of Science ®Google Scholar
• Wang J, Jia L, Li X, et al. New insights into the association between fibrinogen and coronary atherosclerotic plaque vulnerability: an intravascular optical coherence tomography study. Cardiovasc Ther. 2019;2019:1–12. doi:10.1155/2019/8563717
   Web of Science ®Google Scholar
• Papageorgiou N, Briasoulis A, Hatzis G, et al. Coronary artery atherosclerosis in hypertensive patients: the role of fibrinogen genetic variability. Rev Esp Cardiol (Engl Ed). 2017;70(1):34–41. doi:10.1016/j.rec.2016.05.02427553289
   PubMed Web of Science ®Google Scholar
• Sreckovic B, Sreckovic VD, Soldatovic I, et al. Homocysteine is a marker for metabolic syndrome and atherosclerosis. Diabetes Metab Syndr. 2017;11(3):179–182. doi:10.1016/j.dsx.2016.08.02627600468
   PubMed Web of Science ®Google Scholar
• McCully KS. Homocysteine metabolism, atherosclerosis, and diseases of aging. Compr Physiol. 2011;6(4):471–505. doi:10.1002/cphy.c150021
   Web of Science ®Google Scholar
• Agrawal A. CRP after 2004. Mol Immunol. 2005;42(8):927–930. doi:10.1016/j.molimm.2004.09.02815829284
   PubMed Web of Science ®Google Scholar
• Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int. 2001;59(2):407–414. doi:10.1046/j.1523-1755.2001.059002407.x11168922
   PubMed Web of Science ®Google Scholar
• Sun Y, Byon CH, Yang Y, et al. Dietary potassium regulates vascular calcification and arterial stiffness. JCI Insight. 2017;2(19). doi:10.1172/jci.insight.94920
   Web of Science ®Google Scholar
• Johnson LS, Mattsson N, Sajadieh A, Wollmer P, Söderholm M. Serum potassium is positively associated with stroke and mortality in the large, population-based malmö preventive project cohort. Stroke. 2017;48(11):2973–2978. doi:10.1161/STROKEAHA.117.01814828974633
   PubMed Web of Science ®Google Scholar
• Bano A, Chaker L, Mattace-Raso FU, et al. Thyroid function and the risk of atherosclerotic cardiovascular morbidity and mortality: the Rotterdam Study. Circ Res. 2017;121(12):1392–1400. doi:10.1161/CIRCRESAHA.117.31160329089349
   PubMed Web of Science ®Google Scholar
• Åsvold BO, Bjøro T, Nilsen TIL, Gunnell D, Vatten LJ. Thyrotropin levels and risk of fatal coronary heart disease: the HUNT study. Arch Intern Med. 2008;168(8):855–860. doi:10.1001/archinte.168.8.85518443261
   PubMedGoogle Scholar
• Åsvold BO, Vatten LJ, Bjøro T, et al. Thyroid function within the normal range and risk of coronary heart disease: an individual participant data analysis of 14 cohorts. JAMA Intern Med. 2015;175(6):1037–1047. doi:10.1001/jamainternmed.2015.093025893284
   PubMed Web of Science ®Google Scholar
• Chaker L, Baumgartner C, Den Elzen WP, et al. Thyroid function within the reference range and the risk of stroke: an individual participant data analysis. J Clin Endocrinol Metab. 2016;101(11):4270–4282. doi:10.1210/jc.2016-225527603906
   PubMed Web of Science ®Google Scholar
• Rodondi N, Den Elzen WP, Bauer DC, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304(12):1365–1374. doi:10.1001/jama.2010.136120858880
   PubMed Web of Science ®Google Scholar
• Cappola AR, Arnold AM, Wulczyn K, Carlson M, Robbins J, Psaty BM. Thyroid function in the euthyroid range and adverse outcomes in older adults. J Clin Endocrinol Metab. 2015;100(3):1088–1096. doi:10.1210/jc.2014-358625514105
   PubMed Web of Science ®Google Scholar
• Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA. 2006;295(9):1033–1041. doi:10.1001/jama.295.9.103316507804
   PubMed Web of Science ®Google Scholar
• Collet T-H, Gussekloo J, Bauer DC, et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med. 2012;172(10):799–809. doi:10.1001/archinternmed.2012.40222529182
   PubMedGoogle Scholar
• Erikssen G, Liestøl K, Bjørnholt J, Stormorken H, Thaulow E, Erikssen J. Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality. Eur Heart J. 2000;21(19):1614–1620. doi:10.1053/euhj.2000.214810988014
   PubMed Web of Science ®Google Scholar
• Ige A, Adewoye E. Oral magnesium treatment reduces anemia and levels of inflammatory markers in experimental diabetes. J Diet Suppl. 2017;14(1):76–88. doi:10.1080/19390211.2016.120570027459339
   PubMedGoogle Scholar
• Johansson H-E, Haenni A, Zethelius B. Changes in erythrocyte sedimentation rate, white blood cell count, liver enzymes, and magnesium after gastric bypass surgery. J Obes. 2011;2011:1–6. doi:10.1155/2011/273105
   Google Scholar
• Christoffersen C, Bartels ED, Aarup A, Nielsen LB, Pedersen TX. ApoB and apoM–new aspects of lipoprotein biology in uremia-induced atherosclerosis. Eur J Pharmacol. 2017;816:154–160. doi:10.1016/j.ejphar.2017.03.05328351665
   PubMed Web of Science ®Google Scholar
• Kushiyama A, Nakatsu Y, Matsunaga Y, et al. Role of uric acid metabolism-related inflammation in the pathogenesis of metabolic syndrome components such as atherosclerosis and nonalcoholic steatohepatitis. Mediators Inflamm. 2016;2016:1–15. doi:10.1155/2016/8603164
   Web of Science ®Google Scholar